TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-05-11			5-day change	1st Jan Change
42.84 ^CNY	+1.42%		+5.52%	-6.09%

Apr. 30	Singapore Shares Surge More Than 1% as DBS Books Record Total Income	MT
Apr. 30	Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%	MT

Tianjin Pharmaceutical Da Ren Tang to Renew Financial Services Agreement with Tianjin Pharmaceutical Group Finance

Published on 03/30/2026 at 11:55 pm EDT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Apr. 30	Singapore Shares Surge More Than 1% as DBS Books Record Total Income	MT
Apr. 30	Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%	MT
Apr. 29	Tianjin Pharmaceutical Da Ren Tang posts qtrly revenue of RMB1.52 billion	RE
Apr. 29	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Mar. 31	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025	MT
Mar. 31	Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20%	MT
Mar. 30	Tianjin Pharmaceutical Da Ren Tang to Renew Financial Services Agreement with Tianjin Pharmaceutical Group Finance	MT
Mar. 30	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Down 4% in 2025	MT
Mar. 30	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Proposes Final Dividend for Fiscal Year 2025	CI
Mar. 30	Tianjin Pharmaceutical Da Ren Tang 2025 net profit down 4.4%	RE
Mar. 30	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Feb. 06	Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%	MT
Feb. 02	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Interim Dividend for the Financial Year Ended 31 December 2025, Payable on or About February 12, 2026	CI
Dec. 15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces the Cessation of Guo Xiumei as Employee Supervisor	CI
Dec. 15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces the Cessation of Xie Xi as Supervisor	CI

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Duration

Period

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

600329: Dynamic Chart

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Employees

3,890

Sector

Pharmaceuticals

More about the company